During the past decade, Heartland Research Associates, LLC conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 19 clinical trials were completed, i.e. on average, 126.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 10 clinical trials were completed. i.e. 500% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Heartland Research Associates, LLC" #1 sponsor was "Pfizer" with 9 trials, followed by "Bausch Health Americas, Inc." with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Ferring Pharmaceuticals" with 2 trials sponsored and "Bavarian Nordic" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Heartland Research Associates, LLC" #1 collaborator was "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "Accelovance" with 1 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator and "Parexel" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Heartland Research Associates, LLC" are "Chronic Idiopathic Constipation" (3 trials), "Migraine, With or Without Aura" (3 trials), "Acne Vulgaris" (1 trials), "Anthrax" (1 trials) and "Dengue Fever" (1 trials). Many other conditions were trialed in "Heartland Research Associates, LLC" in a lesser frequency.

Most popular intervention types in "Heartland Research Associates, LLC" are "Drug" (15 trials), "Biological" (8 trials), "Other" (4 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Rimegepant" (3 trials), "AV7909" (1 trials), "Adenovirus serotype 26 (Ad26)-based respiratory syncytial virus (RSV). preF" (1 trials) and "BioThrax" (1 trials). Other intervention names were less common.

The vast majority of trials in "Heartland Research Associates, LLC" are 24 trials for "All" genders.

Currently, there are NaN active trials in "Heartland Research Associates, LLC". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Heartland Research Associates, LLC, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Heartland Research Associates, LLC, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".